Betarbet, Ranjita; Poisik, Olga; Sherer, Todd B et al. (2004) Differential expression and ser897 phosphorylation of striatal N-methyl-d-aspartate receptor subunit NR1 in animal models of Parkinson's disease. Exp Neurol 187:76-85
|
Betarbet, Ranjita; Greenamyre, J Timothy (2004) Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP. Exp Neurol 189:393-403
|
Betarbet, Ranjita; Sherer, Todd B; Greenamyre, J Timothy (2002) Animal models of Parkinson's disease. Bioessays 24:308-18
|
Sherer, Todd B; Betarbet, Ranjita; Greenamyre, J Timothy (2002) Environment, mitochondria, and Parkinson's disease. Neuroscientist 8:192-7
|
Blandini, F; Nappi, G; Greenamyre, J T (2001) Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's disease. Ann Neurol 49:525-9
|
Greenamyre, J T (2001) Glutamatergic influences on the basal ganglia. Clin Neuropharmacol 24:65-70
|
Greenamyre, J T; Sherer, T B; Betarbet, R et al. (2001) Complex I and Parkinson's disease. IUBMB Life 52:135-41
|
Betarbet, R; Sherer, T B; MacKenzie, G et al. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3:1301-6
|
Greenamyre, J T (2000) ""Ottorino Rossi"" Award 2000. New targets for therapy in Parkinson's disease: pathogenesis and pathophysiology. Funct Neurol 15:67-80
|
Steece-Collier, K; Chambers, L K; Jaw-Tsai, S S et al. (2000) Antiparkinsonian actions of CP-101,606, an antagonist of NR2B subunit-containing N-methyl-d-aspartate receptors. Exp Neurol 163:239-43
|
Showing the most recent 10 out of 22 publications